Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:09 May,2020

Half of India has almost flattened Covid curve

Seven worst-hit states — Maharashtra, Gujarat, Delhi, Tamil Nadu, Madhya Pradesh, UP and Rajasthan — have distorted the picture for the rest of India, which seems to have almost flattened the curve.
There is a case for a more geographically nuanced approach in high-risk states even as the lockdown is eased substantially in areas that have reined in the spread. ET breaks down the numbers. ....read more

CMAAO Coronavirus Facts and Myth Buster 89

(With inputs from Dr Monica Vasudeva)
801: Monoclonal Antibodies:The use of mAbs directed against infectious pathogens is an area of investigation. The mechanism is not completely understood. Potential uses include prevention or treatment of specific infections.
Most mAbs target proteins on the surface of a virus and neutralize the virus from entering cells. Palivizumab is an antibody against the respiratory syncytial virus (RSV) fusion (F) glycoprotein. It inhibits viral entry into host cells. The therapy got US Food and Drug Administration (FDA) approval for the prevention of RSV infection. ....read more

CMAAO Coronavirus Facts and Myth Buster 88

(With inputs from Dr Monica Vasudeva)
791: Why sudden deaths after cure
In one of the countries amongst 200 people who were suffering from coronavirus, 20 died days after discharge. In the post-mortem, it was found that the active virus was still present in their body. We all know that virus can remain active in the nasal cavity for up to 28 days and in the stool for 3 months. Once the RT PCR is negative, it does not mean that the virus has gone as RT PCR can have 33% false negative in the first test and 15 to 20% false negative with the second test. Also, if the second sample is not a lower respiratory tract sample, the false negative rates are higher. ....read more

Importance of silence

True silence is the silence between the thoughts and represents the true self, consciousness or the soul. It is a web of energized information ready to take all provided there is a right intent. Meditation is the process of achieving silence. Observing silence is another way of deriving benefits of meditation. Many yogis in the past have recommended and observed silence now and then. Mahatma Gandhi spent one day in silence every week. He believed that abstaining from speaking brought him inner peace and happiness. On all such days he communicated with others only by writing on paper....read more

Video of The day

Sepsivac Heat Killed Mycobacterium W as vaccine in COVID



Healthcare News Monitor

Arogya Setu app, Niti Aayog CEO face RSS fire over app links to e-pharma companies
India Today- Rahul Shrivastava

M Narendra Modi’s pet Arogya Setu app and Niti Aayog CEO Amitabh Kant are under attack from the BJP’s affiliate in the Sangh Parivar - Swadeshi Jagran Manch. Manch conveyor Ashwini Mahajan has tagged Prime Minister Narendra Modi in a series of posts on micro-blogging site Twitter complaining that the Arogya Setu app is promoting e-pharma companies that are offering huge discounts and 'threatening neighbourhood pharmacy shops'. Speaking to India Today TV, Ashwini Mahajan said, "The Arogya Setu app has a link which leads out of the app to an e-pharma platform which has four companies. These are foreign-funded companies that are offering discounts on online purchases of medicine and other health items." He added that his organisation has a serious objection to the fact that the CEO of Niti Ayog is promoting these e-pharma companies through a post on Twitter. A Manch activist explained that on the home page of the app there is a recently added link - Aarogyasetu Mitra. If an app subscriber clicks on it a dialogue box opens which informs that it is leading out of the app. The charge is that the Arogya Setu app then leads to a page where there are links for online consultations and e-pharmacy companies - 1MG, OharmEasy, MedLife and NetMeds.

Govt asks pharma firms when remdesivir, the big hope against Covid, can be made in India
The Print- Himani Chandna

After the United States and Japan authorised the use of experimental drug remdesivir to treat Covid-19 patients, the government of India has also begun weighing its options. The Ministry of Health and Family Welfare held a video conference Thursday with top pharmaceutical companies to check the “status” of the drug’s development in India. According to industry sources, major players like Cipla, Glenmark and Dr Reddy’s are working on the development of the injectable drug, which has been developed by Gilead Sciences in the US, and is under patent protection until 2035. Gilead has given the drug the brand name Veklury. Representatives of all three aforementioned firms, along with other Indian pharma companies including Jubilant Life Sciences and Hetero Pharma, attended the meeting chaired by health ministry joint secretary Sudhanshu Pant. “The objective of the meeting was to understand the latest status of remdesivir’s development in India,” a government source told ThePrint. “The industry was asked if companies have reached out to Gilead Sciences, the maker of remdesivir, to initiate talks about voluntary licencing. The ministry also sought details on the process of production once Gilead gives approval, and in how much time the production can be ramped up,” the source said. The moves come after a Covid-19 by a third. Cipla and Jubilant Life Sciences refused to comment on the meeting or the status of remdesivir development in India, while emails sent to Glenmark, Dr Reddy’s and Hetero did not elicit a response until the publication of this report.

Mumbai: Viral video shows bodies of coronavirus victims lying next to patients at Sion hospital
India Today- Kiran Tare

A viral video of patients lying close to bodies wrapped in black polythene bags at a coronavirus ward of a Mumbai hospital has triggered outrage on social media. The viral video shows the pathetic conditions in which coronavirus patients and suspected cases are being kept at the coronavirus ward in Mumbai’s Lokmanya Tilak Hospital. The video, uploaded by BJP MLA Nitesh Rane, shows bodies wrapped in black polythene, lying on the beds close to the patients. In a ward where around 10 patients are being treated there are at least six bodies close to the beds of the patients. “This is the condition of Mumbai’s hospitals. Patients are sleeping close to dead bodies. This is extreme. What kind of administration it is,” the MLA said. The Lokmanya Tilak Hospital, Sion dean Dr. Pramod Ingale in a statement said it is a challenge before the hospital administration to handover the bodies to relatives as the families are reluctant to take them in the middle of the coronavirus situation. “The video seems to be from Sion Hospital. The challenge with us is that relatives are not ready to take the bodies. Usually relatives are behind us to handover the body. In COVID-19 cases, they are not coming forward to collect the body. By the time we disinfect and wrap the body of a COVID-19 patient the relatives disappear. We can’t dispose body on our own. We have to inform local police station and medical health officer about the death,” the statement read.

‘Expect Covid-19 to peak around June-July in India, the way cases are increasing’: AIIMS director
Times Now

The coronavirus pandemic has been spreading exponentially in India over the past few weeks and the total number of cases is rising at an alarming rate if we look at the graph since early April. While the central government is confident of warding off the threat soon, experts and medics still believe the worst is yet to come. With around 53,000 cases across the country and nearly 1,800 deaths over the past four months of the outbreak in India, the threat is very much imminent in this country of over 135 crore people. The Director of All India Institute of Medical Sciences in Delhi, Dr Randeep Guleria, on Thursday said that the peak of the pandemic outbreak is yet to arrive in India and he has predicted it to be at its worst around June-July. “According to modelling data and the way our cases are increasing, it is likely that the peak can come in June and July. But, there are many variables and with time only we will know how much they are effective and the effect of extending the lockdown,” Guleria said. His statements come a day after telling The Indian Express that the curve has not shown a downward trend yet, though the nationwide lockdown has helped flatten it. “The next four to six weeks will be very, very important because the lockdown cannot be there forever,” the AIIMS director had said on Wednesday, adding that “the focus now should be to identify spots that are showing a spike in cases and turn them into containment zones”.